Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR

Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR

We report a case of a pregnant woman with nephrotic syndrome due to biopsy-proven focal segmental glomerulosclerosis (FSGS) whose fetus developed echogenic kidneys and severe oligohydramnios by 27 weeks of gestation. Maternal treatment with prednisone resulted in normalization of the amniotic fluid...

Full description

Bibliographic Details
Main Authors:	Shirley Shuster, Ghada Ankawi, Christoph Licht, Jochen Reiser, Xuexiang Wang, Changli Wei, David Chitayat, Michelle Hladunewich
Format:	Article
Language:	English
Published:	MDPI AG 2018-10-01
Series:	Journal of Clinical Medicine
Subjects:	echogenic kidneys oligohydramnios nephrotic syndrome focal segmental glomerulosclerosis (FSGS) soluble urokinase-type plasminogen activator receptor (suPAR)
Online Access:	http://www.mdpi.com/2077-0383/7/10/324

Similar Items

Primary Focal Segmental Glomerulosclerosis: Why Are Pieces of This Puzzle Still Missing?
by: Hernán Trimarchi
Published: (2015-07-01)

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab
by: Nada Alachkar, et al.
Published: (2018-12-01)

Reassessing the Reassessment of suPAR in glomerular disease
by: Björn eMeijers, et al.
Published: (2015-01-01)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01)

suPAR as a prognostic biomarker in sepsis
by: Donadello Katia, et al.
Published: (2012-01-01)

Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis
by: Panupong Hansrivijit, et al.
Published: (2020-04-01)

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
by: Ioannis Griveas, et al.
Published: (2021-07-01)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
by: Jeppe Meyer, et al.
Published: (2018-02-01)

suPAR as a marker of infection in acute kidney injury – a prospective observational study
by: Anna Hall, et al.
Published: (2018-08-01)

The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine
by: Jan Simon Scharrenberg, et al.
Published: (2019-11-01)

Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis
by: Yumeng Wen, et al.
Published: (2018-04-01)

Regional secondary focal segmental glomerulosclerosis in a transplanted kidney – resolution with treatment of a segmental renal artery stenosis
by: Iwami Daiki, et al.
Published: (2012-06-01)

Disease Recurrence—The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis
by: Katrin Kienzl-Wagner, et al.
Published: (2019-07-01)

Heterozygous COL4A3 Variants in Histologically Diagnosed Focal Segmental Glomerulosclerosis
by: Matthias C. Braunisch, et al.
Published: (2018-06-01)

Focal Segmental Glomerulosclerosis in Children: An Emerging Epidemic and Risk Factors for Disease Recurrence in Transplants
by: Abraham, Elizabeth C., M.D.
Published: (2011)

SuPAR-based choice of the management strategy in kidney transplant recipients with infection
by: N. V. Rapetskaya, et al.
Published: (2020-10-01)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
by: Rabensteiner, Jasmin, et al.
Published: (2016-07-01)

In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia
by: Hernán Trimarchi, et al.
Published: (2017-05-01)

suPAR, a Circulating Kidney Disease Factor
by: Changli Wei, et al.
Published: (2021-10-01)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction
by: Evangelos Terpos, et al.
Published: (2020-10-01)

Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
by: Manuel Alfredo Podestà, et al.
Published: (2020-11-01)

Study of the morphologic variants of focal segmental glomerulosclerosis: a Brazilian report Estudo brasileiro das variantes morfológicas da glomerulosclerose segmentar e focal
by: Leonardo de Abreu Testagrossa, et al.
Published: (2012-06-01)

A Clinico-Pathological Correlation of Childhood Primary Nephrotic Syndrome in Jakarta
by: I. G. N. Wila Wirya
Published: (2019-01-01)

A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report
by: Sho Ishiwa, et al.
Published: (2020-08-01)

suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva: um estudo piloto
by: Joana Silvestre, et al.
Published: (2019-01-01)

Stiffness and echogenicity: Development of a stiffness-echogenicity matrix for clinical problem solving
by: Antonio Stecco, et al.
Published: (2019-09-01)

A clinical case of using therapeutic plasma exchange for the treatment of recurrent focal segmental glomerulosclerosis in a child after kidney transplantation
by: I. A. Miloserdov, et al.
Published: (2021-07-01)

Focal segmental glomerulosclerosis: current status of the problem
by: I. T. Murkamilov, et al.
Published: (2020-01-01)

Non-ischemic cardiomyopathy with focal segmental glomerulosclerosis
by: Parminder Kaur, et al.
Published: (2020-03-01)

Karyomegalic interstitial nephritis with focal segmental glomerulosclerosis: A rare association
by: S Radha, et al.
Published: (2014-01-01)

Frequency and clinicopathological correlations of histopathological variants of pediatric idiopathic focal segmental glomerulosclerosis
by: S Shakeel, et al.
Published: (2014-01-01)

Evaluation of suPAR Levels in Attention Deficit Hyperactivity Disorder Etiopathogenesis
by: Ayşe Irmak, et al.
Published: (2019-03-01)

Prognostic effects of SuPAR and Neopterin Levels on Patients with Lung Cancer
by: Yalcin Selim, et al.
Published: (2020-07-01)

Relationship between loss of echogenicity and cavitation emissions from echogenic liposomes insonified by spectral Doppler ultrasound
by: Radhakrishnan, Kirthi
Published: (2013)

Soluble urokinase plasminogen activator receptor and cardiovascular function in African and Caucasian populations : the SAfrEIC study / Anélda Smith
by: Smith, Anélda
Published: (2011)

Soluble urokinase plasminogen activator receptor and cardiovascular function in African and Caucasian populations : the SAfrEIC study / Anélda Smith
by: Smith, Anélda
Published: (2011)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)

Soluble urokinase-type plasminogen activator receptor (suPAR) – a possible biomarker for bacteremia in sepsis / Forma solubilă a receptorului pentru activatorul de plasminogen de tip urokinază (suPAR) – un biomarker posibil pentru bacteriemie în sepsis
by: Georgescu Anca-Meda, et al.
Published: (2015-03-01)

Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients
by: Nasr El-Din A, et al.
Published: (2021-08-01)

Correlation of kidney biopsy findings and clinical manifestations of primary focal and segmental glomerulosclerosis
by: Taheri Diana, et al.
Published: (2009-01-01)